Kings Point Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$759K Buy
10,010
+1
+0% +$79 0.07% 114
2021
Q4
$854K Sell
10,009
-382
-4% -$29.8K 0.07% 115
2021
Q3
$785K Buy
10,391
+581
+6% +$46.1K 0.07% 119
2021
Q2
$798K Buy
9,810
+1
+0% +$82 0.07% 122
2021
Q1
$773K Buy
9,809
+1
+0% +$78 0.08% 113
2020
Q4
$839K Buy
9,808
+1
+0% +$83 0.09% 109
2020
Q3
$757K Buy
9,807
+1
+0% +$76 0.09% 111
2020
Q2
$718K Buy
9,806
+1
+0% +$71 0.1% 104
2020
Q1
$651K Buy
9,805
+734
+8% +$51.8K 0.11% 96
2019
Q4
$624K Sell
9,071
-3,451
-28% -$235K 0.09% 113
2019
Q3
$920K Sell
12,522
-24
-0.2% -$1.74K 0.16% 90
2019
Q2
$899K Buy
12,546
+4,905
+64% +$348K 0.16% 89
2019
Q1
$524K Hold
7,641
0.1% 98
2018
Q4
$455K Hold
7,641
0.1% 100
2018
Q3
$512K Hold
7,641
0.1% 108
2018
Q2
$495K Hold
7,641
0.1% 112
2018
Q1
$548K Hold
7,641
0.11% 107
2017
Q4
$577K Sell
7,641
-500
-6% -$36.5K 0.12% 104
2017
Q3
$593K Hold
8,141
0.13% 97
2017
Q2
$603K Sell
8,141
-48
-0.6% -$3.56K 0.14% 101
2017
Q1
$599K Sell
8,189
-43,313
-84% -$3.03M 0.14% 93
2016
Q4
$3.37M Sell
51,502
-3,884
-7% -$266K 0.83% 46
2016
Q3
$4.11M Sell
55,386
-883
-2% -$65.3K 1.08% 34
2016
Q2
$4.12M Buy
56,269
+1,569
+3% +$112K 1.05% 38
2016
Q1
$3.87M Sell
54,700
-49,730
-48% -$3.31M 0.98% 35
2015
Q4
$6.96M Buy
104,430
+9,970
+11% +$663K 1.72% 22
2015
Q3
$5.99M Buy
94,460
+1,960
+2% +$128K 1.58% 26
2015
Q2
$6.05M Sell
92,500
-251
-0.3% -$17K 1.47% 27
2015
Q1
$6.43M Buy
92,751
+530
+0.6% +$36.6K 1.61% 24
2014
Q4
$6.38M Buy
92,221
+1,598
+2% +$108K 1.72% 24
2014
Q3
$5.91M Sell
90,623
-1,556
-2% -$103K 1.79% 24
2014
Q2
$6.29M Buy
92,179
+594
+0.6% +$39.8K 1.89% 22
2014
Q1
$5.94M Buy
91,585
+8,027
+10% +$506K 1.93% 21
2013
Q4
$5.45M Buy
83,558
+2,887
+4% +$185K 1.91% 20
2013
Q3
$4.78M Sell
80,671
-617
-0.8% -$36.6K 1.84% 22
2013
Q2
$4.66M Buy
+81,288
New +$4.83M 1.89% 20

Other funds holding CL

Kings Point Capital Management's CL Position: Q1 2022 in Review

Kings Point Capital Management increased its Colgate-Palmolive (CL) stake by 0.01% in Q1 2022, buying an estimated $79 and bringing the position to 10,010 shares worth $759K. The position accounts for 0.07% of the portfolio, ranked #114.

Kings Point Capital Management first reported a position in CL in Q2 2013 and has held it in 36 quarters since. The position peaked at $6.96M in Q4 2015. 1,632 funds tracked by Wall St. Rank hold CL as of Q1 2022.

  • Kings Point Capital Management held 10,010 shares of Colgate-Palmolive worth $759K as of Q1 2022.
  • Kings Point Capital Management bought 1 Colgate-Palmolive share in Q1 2022, an estimated $79.
  • Colgate-Palmolive made up 0.07% of Kings Point Capital Management's portfolio in Q1 2022, its #114 holding.
  • Kings Point Capital Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 36 quarters since.
  • Kings Point Capital Management's Colgate-Palmolive position peaked at $6.96M in Q4 2015.
  • 1,632 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2022.

Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.